Filtra per Last updated date ScegliereDopoPrimaFrom - To Data Data di conclusione Questa settimana Questo mese Ultima settimana Ultimo mese Category HumanCorporateVeterinaryHerbal Topic MedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesCorporateGeneric and hybrid medicinesEarly accessMedicines for use outside the EUFeesProduct informationMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurement Diseases area Viral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDS Responsible body CHMP CVMP PRAC Management Board COMP PDCO CMDh HMPC CAT Patient safety Yes Leave this field blank Filtra Risultati (3786) Sort by Last update date (new to old)Last update date (old to new)A-ZZ-A Leave this field blank Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2023 EMA’s human medicines committee (CHMP) recommended eight medicines. 10 Novembre 2023 News Human Medicines Referrals Getting ready for EMA’s website relaunch on 5 December 2023 9 Novembre 2023 News Corporate Global regulators celebrate 10 years of strategic leadership and cooperation 9 Novembre 2023 News Human Medicines First electronic product information (ePI) published for selected human medicines 8 Novembre 2023 News Data on medicines Product information EMA encourages companies to submit type I variations for 2023 in November 2023 3 Novembre 2023 News Corporate Medicines Call for expressions of interest for patients’ organisations representatives to join Committee for Orphan Medicinal Products (COMP) 3 Novembre 2023 News Human Corporate Medicines Call for expression of interest for independent scientific experts to participate in the work of EMA’s Safety Committee 3 Novembre 2023 News Human Corporate Medicines EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5 31 Ottobre 2023 News Human COVID-19 Vaccines EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November 30 Ottobre 2023 News Corporate Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2023 27 Ottobre 2023 News Human Pharmacovigilance Referrals 1 … 20 21 22 23 24 Page 24 of 379 25 26 27 28 … 379
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2023 EMA’s human medicines committee (CHMP) recommended eight medicines. 10 Novembre 2023 News Human Medicines Referrals
Global regulators celebrate 10 years of strategic leadership and cooperation 9 Novembre 2023 News Human Medicines
First electronic product information (ePI) published for selected human medicines 8 Novembre 2023 News Data on medicines Product information
EMA encourages companies to submit type I variations for 2023 in November 2023 3 Novembre 2023 News Corporate Medicines
Call for expressions of interest for patients’ organisations representatives to join Committee for Orphan Medicinal Products (COMP) 3 Novembre 2023 News Human Corporate Medicines
Call for expression of interest for independent scientific experts to participate in the work of EMA’s Safety Committee 3 Novembre 2023 News Human Corporate Medicines
EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5 31 Ottobre 2023 News Human COVID-19 Vaccines
EMA business hours over All Saints' Day and All Souls' Day, 1 and 2 November 30 Ottobre 2023 News Corporate
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 23-26 October 2023 27 Ottobre 2023 News Human Pharmacovigilance Referrals